Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

97 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Infigratinib Versus Placebo for Patients with High-risk Resected Urothelial Cancer Bearing an FGFR3 Genomic Alteration: Results from the PROOF302 Phase 3 Trial.
Pal SK, Grivas P, Gupta S, Dizman N, Zengin Z, Valderrama BP, Rodriguez-Vida A, Roghmann F, Sevillano Fernandez E, Matin SF, Loriot Y, Sridhar SS, Sonpavde G, Fleming MT, Lerner SP, Bellmunt J, Master V, Tripathi A, Davis K, van Veenhuyzen D, Weng R, Daneshmand S. Pal SK, et al. Eur Urol. 2024 Apr 4:S0302-2838(24)02247-4. doi: 10.1016/j.eururo.2024.03.023. Online ahead of print. Eur Urol. 2024. PMID: 38580518 No abstract available.
Muscle invasive bladder cancer: where is the field headed?
Ghatalia P, Kaur J, Sonpavde G. Ghatalia P, et al. Expert Opin Biol Ther. 2023 Jul-Dec;23(9):913-927. doi: 10.1080/14712598.2023.2238607. Epub 2023 Jul 21. Expert Opin Biol Ther. 2023. PMID: 37477127 Review.
Adjuvant Pembrolizumab versus Observation in Muscle-Invasive Urothelial Carcinoma.
Apolo AB, Ballman KV, Sonpavde G, Berg S, Kim WY, Parikh R, Teo MY, Sweis RF, Geynisman DM, Grivas P, Chatta G, Reichert ZR, Kim JW, Bilen MA, McGregor B, Singh P, Tripathi A, Cole S, Simon N, Niglio S, Ley L, Cordes L, Srinivas S, Huang J, Odegaard M, Watt C, Petrylak D, Hoffman-Censits J, Wen Y, Hahn O, Mitchell C, Tan A, Streicher H, Sharon E, Moon H, Woods M, Halabi S, Perez Burbano G, Morris MJ, Rosenberg JE. Apolo AB, et al. N Engl J Med. 2024 Sep 15. doi: 10.1056/NEJMoa2401726. Online ahead of print. N Engl J Med. 2024. PMID: 39282902
Comparative real-world survival outcomes of muscle-invasive bladder cancer treated with bladder-only vs. whole-pelvis concurrent chemoradiation.
Riveros C, Ranganathan S, Haque W, Huang E, Xu J, Kulkarni GS, Geng M, Anis M, Muhammad T, Chan KS, Farach A, Teh BS, Miles BJ, Klaassen Z, Sonpavde GP, Wallis CJD, Satkunasivam R. Riveros C, et al. Among authors: sonpavde gp. Can Urol Assoc J. 2024 Feb;18(2):17-24. doi: 10.5489/cuaj.8386. Can Urol Assoc J. 2024. PMID: 37931278 Free PMC article.
Impact of Angiotensin Converting Enzyme Inhibitors on Pathologic Complete Response With Neoadjuvant Chemotherapy for Muscle Invasive Bladder Cancer.
Skelton WP 4th, Masur J, Thomas J, Fallah P, Jain RK, Ravi P, Mantia C, McGregor BA, Nuzzo PV, Adib E, Zarif TE, Preston MA, Clinton TN, Li R, Steele GS, Kassouf W, Freeman D, Pond GR, Jain RK, Sonpavde GP. Skelton WP 4th, et al. Among authors: sonpavde gp. Clin Genitourin Cancer. 2024 Oct;22(5):102143. doi: 10.1016/j.clgc.2024.102143. Epub 2024 Jun 24. Clin Genitourin Cancer. 2024. PMID: 39032202
Vaccine approaches to treat urothelial cancer.
Giudice GC, Sonpavde GP. Giudice GC, et al. Among authors: sonpavde gp. Hum Vaccin Immunother. 2024 Dec 31;20(1):2379086. doi: 10.1080/21645515.2024.2379086. Epub 2024 Jul 23. Hum Vaccin Immunother. 2024. PMID: 39043175 Free PMC article. Review.
97 results